Frontiers | N-Linked Glycosylation Regulates CD22 Organization and Function
CD22- What A Powerful Co-receptor of B Cell Receptor-CUSABIO
Cancers | Free Full-Text | CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
IJMS | Free Full-Text | Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments
CD22 - an overview | ScienceDirect Topics
What Is The Cell Surface Marker- CUSABIO
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR: Molecular Therapy
CD22 Monoclonal Antibody (2D6), PE (MCD2204)
CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction - ScienceDirect
CD22 Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Pharmaceuticals | Free Full-Text | Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development
---Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-54473-img0005.jpg "Siglec-2/CD22 Antibody (BLCAM/1795) - Azide and BSA Free (NBP2-54473): Novus Biologicals")
Siglec-2/CD22 Antibody (BLCAM/1795) - Azide and BSA Free (NBP2-54473): Novus Biologicals
Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis | ACS Chemical Biology
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL: Molecular Therapy
CD22 Antibody (D-5) | SCBT - Santa Cruz Biotechnology
Frontiers | CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
CD22 Antibody | Cell Signaling Technology
Cancers | Free Full-Text | CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
CD22 is a negative regulator of B-cell receptor signalling: Current Biology
CD22 (E7L6Z) XP® Rabbit mAb | Cell Signaling Technology
Frontiers | CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
Coordinated changes in glycosylation regulate the germinal center through CD22 - ScienceDirect
Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling | The EMBO Journal
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Full article: Distinct Endocytic Mechanisms of CD22 (Siglec-2) and Siglec-F Reflect Roles in Cell Signaling and Innate Immunity
CD22/BL-CAM (B-Cell Marker) Recombinant Monoclonal Antibody (rBLCAM/6749) (933-MSM9-P1)
